Biotest Aktiengesellschaft (ETR:BIO - Get Free Report)'s stock price traded down 1% on Wednesday . The company traded as low as €41.00 ($43.16) and last traded at €41.00 ($43.16). 508 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 1,927 shares. The stock had previously closed at €41.40 ($43.58).
Biotest Aktiengesellschaft Trading Up 0.5 %
The company has a quick ratio of 1.66, a current ratio of 2.45 and a debt-to-equity ratio of 116.50. The firm has a market cap of $823.26 million, a P/E ratio of 9.98 and a beta of 0.24. The firm's 50-day simple moving average is €41.55 and its 200 day simple moving average is €41.63.
Biotest Aktiengesellschaft Company Profile
(
Get Free Report)
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Further Reading
Before you consider Biotest Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biotest Aktiengesellschaft wasn't on the list.
While Biotest Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
